Key result
Exercise-based cardiovascular rehabilitation trials heavily underrepresent women, who comprise only ~16% of enrolled patients.
Systematic Review (n=23,779)
Cardiovascular rehabilitation trials are heavily biased toward male populations, highlighting a critical need for gender-balanced enrollment and gender-based analyses in future research.
Answers are grounded in this paper and cite their sources.
Limits generalizability of CV rehab evidence to women; challenges trial inclusivity and extends calls for gender-balanced enrollment.
The existence of gender differences in cardiovascular risk factors, cardiovascular disease (CVD) pathophysiology, comorbidities and treatment effects is well established in the scientific literature, and their clinical relevance to the management of CVD is known.1 Compared with men, women tend to exhibit different physiological responses to drugs and exercise-based interventions,2–4 especially in specific life periods, with sex hormones playing a key role in both cardiovascular function and performance.5,6 It has been pointed out that most treatments are tested mainly in middle-aged men, with the findings mechanically transferred to women of all ages.7,8 The aim of the present systematic overview was to detect and quantify any gender imbalance in the context of exercise-based rehabilitative interventions for persons with established CVD. The Cochrane collaboration is internationally recognised as the highest standard in evidence-based medicine, as well as the largest single source of systematic reviews (SRs) of randomised controlled trials (RCTs) in healthcare, with 7695 reviews published at the time of writing.9 Cochrane SRs are aimed at providing high-quality, independent evidence for healthcare decision-making based on data from RCTs. Furthermore, compared with non-Cochrane reviews in the rehabilitation field, it has been shown that Cochrane SRs have higher methodological quality.10 Accordingly, we have chosen to limit our search to Cochrane SRs only, by using the most recent version of the database of meta-analytically pooled data from exercise-based intervention trials in persons with CVD. A systematic search of the Cochrane SRs was conducted (http://www.cochranelibrary.com/). The SRs were selected by topic (‘heart and circulation’), type of article (‘review’), and methodology (‘intervention’). The database was searched to April 2018. The Cochrane SRs included in this analysis had to meet the following inclusion criteria: (a) SRs of RCTs enrolling adults aged over 18 years with established CVD;11 and (b) SRs of studies comparing exercise-based interventions with a non-active control that could include usual medical care. Titles and abstracts of potentially relevant reviews were independently assessed by the two authors (LC and GM). The full texts of the selected SRs were then independently screened by the authors, who identified and recorded the reasons for exclusion of ineligible SRs. Any disagreement was resolved by discussion. A standardised data extraction form was used to collect the main characteristics of each SR and of the related RCTs selected for inclusion. The first author (LC) extracted the SRs together with the RCT characteristics, whereas the second author (GM) checked all the extracted data for accuracy. Concerning the inclusion criteria, any disagreements with respect to data extraction were resolved by discussion. In the case of unclear or missing data in the full text of the SR, the gap was filled by checking the references of the individual RCTs. The following details were collected for each SR: title; author name(s); year of publication and issue; Cochrane review group; CVD population; primary and secondary outcomes and the presence of a subgroup analysis according to gender; number of trials included and year range of publication; pooled population and average age of analysed subjects; number of trials including both sexes, only men, or only women; and total number of subjects according to gender and related percentages. A comprehensive flowchart of the selection process for the Cochrane SRs is presented in Figure 1. Flow chart for the study selection. SR: systematic review; CVExR: cardiovascular exercise-based rehabilitation; RCT: randomised controlled trial; HF: heart failure; CHD: coronary heart disease; HVS: heart valve surgery; CVI: chronic venous insufficiency; IC: intermittent claudication. Eight SRs focusing on exercise-based interventions for persons with established CVD11 met all the eligibility criteria and were included in this analysis. The eight selected SRs were conducted by the Cochrane heart group12–17 or the Cochrane vascular group18,19 between 2014 and 2018, and included 155 RCTs enrolling a total of 23,779 persons with CVD. Overall, the SRs were focused on heart failure,12 coronary heart disease,13 heart valve surgery,14 non-ulcerative chronic venous insufficiency,18 atrial fibrillation,15 heart transplant,16 intermittent claudication19 and stable angina.17 All studies analysed the effects of exercise-based interventions (supervised or unsupervised inpatient, outpatient and community or home-based programmes) performed alone or in combination with psychosocial or educational interventions, or both (i.e. comprehensive cardiovascular rehabilitation). All comparative groups received usual care treatments that could include standard medical care, such as drug therapy, but without any form of structured exercise training. Of the 155 RCTs, 112 enrolled participants of both sexes, 36 enrolled only men, and one enrolled only women. However, in six studies, gender-based data were not disclosed. Overall, the trials included 18,700 men (78.6%) and 3909 women (16.4%), with percentages among the studies ranging from 44.4%19 to 86.9%17 for men, and from 12.8%13 to 35.8%14 for women. Gender-based data were not disclosed for 1170 persons (4.9%). The patients' mean age ranged from 45 to 81 years; however, in four reviews, the participants' mean age was not clearly stated.14,15,18,19 Finally, a subgroup analysis according to gender was planned for four of the eight Cochrane SRs analysed, although the specific forest plots for those outcomes to be re-evaluated by the subgroup analysis were not reported.12,14,15,17 The main characteristics of the included Cochrane SRs are detailed in Table 1. Characteristics of Cochrane systematic reviews on exercise-based interventions for persons with cardiovascular disease. RCT: randomised controlled trial; CVD: cardiovascular disease; M: male; F: female; BG: both sexes; OM: only men; OW: only women; NR: data not reported; Y: yes; N: no; HF: heart failure; HFPEF: heart failure preserved ejection fraction; HFREF: heart failure reduced ejection fraction; HRQOL: health-related quality of life; CHD: coronary heart disease; MI: myocardial infarction; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; HVS: heart valve surgery; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction; CVI: chronic venous insufficiency; ABI: ankle-brachial index. Characteristics of Cochrane systematic reviews on exercise-based interventions for persons with cardiovascular disease. RCT: randomised controlled trial; CVD: cardiovascular disease; M: male; F: female; BG: both sexes; OM: only men; OW: only women; NR: data not reported; Y: yes; N: no; HF: heart failure; HFPEF: heart failure preserved ejection fraction; HFREF: heart failure reduced ejection fraction; HRQOL: health-related quality of life; CHD: coronary heart disease; MI: myocardial infarction; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; HVS: heart valve surgery; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction; CVI: chronic venous insufficiency; ABI: ankle-brachial index. The present overview of SRs compiled in the framework of the Cochrane Database of SRs revealed that published reports on exercise-based cardiovascular rehabilitation for established CVD tend to be biased towards male populations, as indicated by the strikingly higher number of male patients enrolled than female patients. Approximately 25% of the RCTs included in the present overview did not include women. Moreover, in those studies that enrolled participants of both sexes, women were much less represented than men (overall, 16.4% vs. 78.6%). Accordingly, in the three SRs that were found to include the highest number of RCTs, the percentages of enrolled women were 26.6%,12 16.9%,19 and 12.8%,13 which are four to eight times smaller than the percentages of enrolled men. In a recent study conducted in patients with heart failure, female gender was found to be one of the most important predictors of the reduced walking performance observed in this population (i.e. –34.13 m in the six-minute walking test), along with an increased body mass index and a retired status.20 Furthermore, the studies by Gardner and colleagues in 2010 and 2015 have shown that several cardiovascular rehabilitation outcome measures were different between men and women with intermittent claudication, as women presented with a greater impairment of walking ability21 as well as peripheral muscular and endothelial functions.22 Our data indicate that although there have been attempts in recent years to include an equal number of women and men in trials, studies focusing on CVD frequently lack gender-balanced8,23–25 and gender-based analyses.26 Indeed, a subgroup analysis according to gender was planned for only half of the SRs selected in our study, although additional forest plots from the subgroup gender analysis were not reported.12,14,15,17 With these considerations in mind, it seems imperative to design adequately powered RCTs enrolling gender-balanced cohorts across the subcategories of persons with CVD in the future. Moreover, considering the authoritative and highly influential role of the Cochrane reviews in clinical practice, Cochrane reviewers and meta-analysts should consider collecting and analysing gender-based data, which can be directly requested to the authors of the primary articles, hoping that authors contacted respond by providing the requested data.26 As a final remark and in line with the findings of a similar approach previously developed by Johnson et al. in 2003,27 in an era when health professionals make therapeutic choices and provide treatments in accordance with evidence-based medicine guidelines, the availability of these gender-based data is crucial to ensure the accurate application of treatment strategies to the entire population. This overview indicates that the scientific literature on exercise-based interventions for persons with established CVD is biased toward findings mainly obtained from the male population. This could be amended on two levels: Researchers must enrol a balanced number of men and women, and then conduct gender-based analyses irrespective of whether a disparity between the sexes is noted. Reviewers and meta-analysts of Cochrane SRs, which are the key sources among the extensive array of data from RCTs, should conduct investigations according to gender in their planned subgroup analyses. If applied, the proposed gender-based approach would be likely to lead to a better quality of evidence, which, in turn, would result in an improved and tailored healthcare management for patients with CVD. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this study was supported by grant 2015 from the Italian Society of Cardiology and MSD Italia-Merck Sharp & Dohme Corporation, for the implementation of the project, Physical exercise and therapy: an integrated approach for the reduction of cardiovascular risk and health promotion, at St George's, University of London, UK.
No takes yet. Share an insight, caveat, or question.
Cugusi et al. (2018) conducted a systematic review in Cardiovascular disease (n=23,779). Exercise-based interventions vs. Non-active control (usual medical care) was evaluated on Gender representation (proportion of enrolled women vs men). Exercise-based cardiovascular rehabilitation trials are heavily biased toward male populations, with women representing only 16.4% of enrolled patients and 25% of trials excluding women entirely.
Synapse has enriched 10 related papers. Consider them for comparative context: